Why Champion Iron, Lindian Resouces, McMillan Shakespeare, and Nuix shares are rising

These ASX shares are having a solid start to the week.

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has given back its morning gains and dropped into the red. At the time of writing, the benchmark index is down 0.3% to 7,383.9 points.

Four ASX shares that are not letting that hold them back today are listed below. Here's why they are pushing higher:

Champion Iron Ltd (ASX: CIA)

The Champion Iron share price is up 2.5% to $5.99. This morning, in response to its quarterly update, analysts at Goldman Sachs reiterated their buy rating on this iron ore miner's shares with a $7 price target. The broker believes that "CIA is at a FCF and possibly capital returns inflection point."

Lindian Resources Ltd (ASX: LIN)

The Lindian Resources share price is up 4% to 38.5 cents. This follows the release of promising assay results from the phase two deep diamond drilling at the Kangankunde rare earth project in Malawi. Management believes these results indicate that "the project will play an important role in the rare earths industry to stabilise and balance supply for multiple generations."

McMillan Shakespeare Ltd (ASX: MMS)

The McMillan Shakespeare share price is up 4% to $19.85. This may have been driven by a broker note out of Macquarie this morning. Its analysts have upgraded this salary packaging company and its rival on the belief that supply is improving and electric vehicles are driving increased demand. Macquarie has an outperform rating and a $20.47 price target on the company's shares.

Nuix Ltd (ASX: NXL)

The Nuix share price is up a further 7% to $1.62. Investors have been scrambling to buy this investigative analytics and intelligence software provider's shares since it released its provisional full-year results last week. Nuix expects its underlying EBITDA to be between $44 million and $47 million in FY 2023. This will be up 51% to 61% on FY 2022's EBITDA. Its shares have now almost doubled in July.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended McMillan Shakespeare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »